Compare AMC & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMC | MLAB |
|---|---|---|
| Founded | 1920 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Movies/Entertainment | Industrial Machinery/Components |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 577.2M | 461.9M |
| IPO Year | 2007 | 1995 |
| Metric | AMC | MLAB |
|---|---|---|
| Price | $1.11 | $90.33 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 4 | 1 |
| Target Price | $2.03 | ★ $94.00 |
| AVG Volume (30 Days) | ★ 24.6M | 108.9K |
| Earning Date | 05-06-2026 | 02-03-2026 |
| Dividend Yield | N/A | ★ 0.72% |
| EPS Growth | N/A | ★ 99.24 |
| EPS | N/A | ★ 1.95 |
| Revenue | ★ $4,848,900,000.00 | N/A |
| Revenue This Year | $10.60 | $6.07 |
| Revenue Next Year | $4.72 | $5.41 |
| P/E Ratio | ★ N/A | $46.71 |
| Revenue Growth | ★ 4.57 | N/A |
| 52 Week Low | $0.93 | $59.63 |
| 52 Week High | $4.08 | $128.55 |
| Indicator | AMC | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | 51.93 | 60.82 |
| Support Level | N/A | $70.97 |
| Resistance Level | $1.25 | $97.56 |
| Average True Range (ATR) | 0.07 | 3.20 |
| MACD | 0.02 | 1.23 |
| Stochastic Oscillator | 94.74 | 98.30 |
AMC Entertainment Holdings Inc is involved in the theatrical exhibition business. The company owns, operates, or has interests in theatres located in the United States and Europe. It provides amenities such as plush, power recliners, MacGuffins full bars, AMC Dine-In Theatres, and premium presentation. The company has identified two reportable segments and reporting units for its theatrical exhibition operations, U.S. markets and International markets. It derives key revenue from the U.S.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.